Output Explorer

Case: 2:13-CV-00170-EAS-EPD Doc #: 133 Filed: 10/06/15 Page: 52 of 307 PAGEID #: 5053
Vol. 12 -
52
A.
Yes .
Study directors are always useful at meetings like
this .
3
Q.
During your personal observations during those two days
of the meetings, did any of the industry representatives
5
dominate the discussions or the voting?
A .
No
7
Q .
Were the industry folks lobbying for higher numbers for
8
the screening level?
A .
No .
10
Q .
Bottom line, Dr. Dourson, did it appear to you that the
11
CATT team process was an unbiased process with an open
12
discussion of the science based on the knowledge at the time?
13
A.
Absolutely.
14
Sir, did anyone coerce you or improperly influence you
15
in any way to arrive at 150 part per billion number?
16
A.
No .
17
Q .
Before I sit down, sir, have you ever testified for me
BT
before?
19
A.
No.
20
Q.
Have you ever testified for anyone from my law firm,
21
Squire Sanders or Squire Patton Boggs before?
22
A.
No.
23
Q.
Have you ever been employed by Dupont?
24
A.
No.
25
Q .
Do you own any stock in DuPont?
Source: https://www.industrydocuments.ucsf.edu/docs/jqbn0226

Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.